AI Article Synopsis

  • MMAE (middle meningeal artery embolization) is being investigated as an effective treatment for chronic subdural hematoma (cSDH), focusing on its efficiency based on the cause and structure of cSDH.
  • A study with 52 patients treated with MMAE analyzed pre- and post-treatment cSDH thickness and volume using CT imaging, comparing both spontaneous and traumatic cases.
  • Results showed a significant reduction in cSDH thickness and volume for both groups, with spontaneous cases showing more improvement at 6-12 months, suggesting long-term follow-up may be crucial for traumatic cases.

Article Abstract

: MMAE (middle meningeal artery embolization) has emerged as a potential effective treatment for cSDH (chronic subdural hematoma). In this study, MMAE efficiency with regards to cSDH cause and architecture was explored. The comparability of cSDH thickness and volume as parameters for cSDH pre- and post-MMAE assessment was also analyzed. : In this retrospective cohort study, 52 consecutive cSDH patients treated with MMAE in a single tertiary center were included. The cohort was divided into two group pairs pertaining to cSDH cause (spontaneous or traumatic) and cSDH architecture (non-mature or mature). The radiological outcome was compared in each group before and after MMAE and between each group pair using CT imaging. A correlation analysis between cSDH thickness and volume before and after MMAE was also performed. : A statistically significant positive linear association between cSDH thickness and volume at admission and at each follow-up interval (1-3, 3-6, 6-12 months) was noticed. cSDH thickness and volume reduction in each group was statistically significant, except for a traumatic cSDH volume reduction at 6-12 months. There was no statistically significant difference between each group pair in the cSDH thickness and volume reduction difference at all the follow-up intervals. : A comparable efficiency of MMAE may be achieved in non-mature and mature as well as in spontaneous and traumatic cSDH, with an advantage for spontaneous cSDH at 6-12 months follow-up compared to traumatic cSDH. Traumatic cSDH may require a relatively long-term follow-up post-MMAE. cSDH thickness and volume, as parameters for pre- and post-MMAE cSDH evaluation, appear similar.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11591691PMC
http://dx.doi.org/10.3390/brainsci14111097DOI Listing

Publication Analysis

Top Keywords

csdh thickness
24
thickness volume
24
traumatic csdh
20
csdh
18
6-12 months
12
volume reduction
12
radiological outcome
8
middle meningeal
8
meningeal artery
8
artery embolization
8

Similar Publications

Article Synopsis
  • The study focuses on evaluating the long-term outcomes and natural history of chronic subdural hematoma (cSDH) treatment using middle meningeal artery (MMA) embolization over a 12-month period.
  • A retrospective analysis was conducted involving 49 patients who underwent MMA embolization, detailing patient demographics and various clinical outcomes, including symptom resolution and recurrence rates.
  • Results indicated significant clinical improvement in patients within one month post-procedure, with many elderly patients (average age 73) experiencing previous trauma mainly due to falls.
View Article and Find Full Text PDF

Bilateral middle meningeal artery embolization for the treatment of bilateral chronic subdural hematoma.

Clin Neurol Neurosurg

January 2025

Department of Neurological Surgery, Northwestern Memorial Hospital, Northwestern University Feinberg School of Medicine, 259 E Erie St 19th Floor, Chicago, IL 60611, USA; Department of Radiology, Northwestern Memorial Hospital, Northwestern University Feinberg School of Medicine, 676 N St Clair St, Chicago, IL 60611, USA; Department of Neurology, Northwestern Memorial Hospital, Northwestern University Feinberg School of Medicine, 259 E Erie St 19th Floor, Chicago, IL 60611, USA. Electronic address:

Article Synopsis
  • Middle meningeal artery embolization (MMAE) is gaining popularity as a treatment for chronic subdural hematoma (CSDH), but the specific outcomes of bilateral MMAE (bMMAE) have not been thoroughly analyzed in existing research.
  • In a study involving 28 patients aged around 75, only 17.9% showed complete resolution of their bilateral CSDH after bMMAE, with some still experiencing symptoms, leading to reoperation in 17.9% of cases.
  • The results suggest that while bMMAE may be effective, more research is needed to identify which patients would benefit the most from this treatment approach.
View Article and Find Full Text PDF
Article Synopsis
  • Chronic subdural hematoma (cSDH) primarily affects older adults, is often recurrent after treatment, and can lead to severe complications, including death, with inflammation playing a significant role in its development.
  • The study analyzed cases of cSDH operated on between 2018 and 2020 by reviewing data on sociodemographics, clinical factors, laboratory indices, and treatment outcomes, focusing on their association with the thickness of the cSDH.
  • Out of 72 patients studied, most were elderly with common chronic conditions, and the research found a median Glasgow Outcome Score (GOS) of 5 at discharge and 1 year, with notable rates of recurrence and resurgery occurring within a year post-treatment
View Article and Find Full Text PDF

Radiological Outcome of Middle Meningeal Artery Embolization in Relation to Chronic Subdural Hematoma Cause and Architecture.

Brain Sci

October 2024

Division of Neuroradiology, Joint Department of Medical Imaging, Toronto Western Hospital, University Health Network, Toronto, ON M5T 2S8, Canada.

Article Synopsis
  • MMAE (middle meningeal artery embolization) is being investigated as an effective treatment for chronic subdural hematoma (cSDH), focusing on its efficiency based on the cause and structure of cSDH.
  • A study with 52 patients treated with MMAE analyzed pre- and post-treatment cSDH thickness and volume using CT imaging, comparing both spontaneous and traumatic cases.
  • Results showed a significant reduction in cSDH thickness and volume for both groups, with spontaneous cases showing more improvement at 6-12 months, suggesting long-term follow-up may be crucial for traumatic cases.
View Article and Find Full Text PDF
Article Synopsis
  • Chronic subdural hematoma (CSDH) is becoming more prevalent, particularly among older adults and those using blood thinners, prompting a study to analyze its internal structure and recurrence risk factors.
  • This retrospective analysis included data from 189 patients who underwent surgery between 2014 and 2018, focusing on demographics, clinical details, CT scans, and outcomes evaluated 4-12 weeks post-surgery.
  • The study found that male patients with higher BMI, arterial hypertension, and anticoagulant use were common, with an 18.6% recurrence rate; significant predictors for recurrence included the type of hematoma and midline shift seen on CT scans, while most patients experienced favorable outcomes post-surgery.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!